AI-driven discovery of natural product-derived FAK1 inhibitors for idiopathic pulmonary fibrosis - Xing-Yi Chen; Mei-Hong Lu; Bin Li; Ya Zhou; Li Liu; Hao Yang; Qiu-Yu Wang; Lin Chang; Yu-Lan Zhao; Dong-Mei Wang; Bin Li; Ben-Rong Mu (Molecular Diversity, 2026)

First evidence of CP violation in beauty baryon to charmonium decays - R. Aaij; A.S.W. Abdelmotteleb; C. Abellan Beteta; F. Abudinén; T. Ackernley; A.A. Adefisoye; B. Adeva; M. Adinolfi; P. Adlarson; C. Agapopoulou; C.A. Aidala; Z. Ajaltouni; et al. (Science Bulletin, 2026)

The critical role of mitophagy in cell senescence-mediated pulmonary fibrosis and potential therapeutic strategies - Xing-Yi Chen; Dong-Mei Wang; Ya Zhou; Li Liu; Tao Zhu; Zhao Ran; Mei-Hong Lu; Ben-Rong Mu (Molecular Biology Reports, 2025)

Study of D s 1 ( 2460 ) + → D s + π + π - in B → D ‾ ( * ) D s + π + π - decays - R. Aaij; A.S.W. Abdelmotteleb; C.Abellan Beteta; F. Abudinén; T. Ackernley; A.A. Adefisoye; B. Adeva; M. Adinolfi; P. Adlarson; C. Agapopoulou; C.A. Aidala; Z. Ajaltouni; et al. (Science Bulletin, 2025)

Parkinson's Disease and the Microbiota-Gut-Brain Axis: Metabolites, Mechanisms, and Innovative Therapeutic Strategies Targeting the Gut Microbiota - Zhao Ran; Ben-Rong Mu; Dong-Mei Wang; Xin-Huang; Quan-Hong Ma; Mei-Hong Lu (Molecular Neurobiology, 2025)

Targeting mitophagy for neurological disorders treatment: advances in drugs and non-drug approaches - Xiong Yang; Yu Zhang; Jia-xin Luo; Tao Zhu; Zhao Ran; Ben-Rong Mu; Mei-Hong Lu (Naunyn-Schmiedeberg's Archives of Pharmacology, 2023)